154 related articles for article (PubMed ID: 38326207)
1. The accessibility of pharmacist prescribing and impacts on medicines access: A systematic review.
Walpola RL; Issakhany D; Gisev N; Hopkins RE
Res Social Adm Pharm; 2024 May; 20(5):475-486. PubMed ID: 38326207
[TBL] [Abstract][Full Text] [Related]
2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of pharmacist-led medicines review services in New Zealand - is there equity for Māori older adults?
Hikaka J; Hughes C; Jones R; Connolly MJ; Martini N
Res Social Adm Pharm; 2019 Dec; 15(12):1383-1394. PubMed ID: 30733137
[TBL] [Abstract][Full Text] [Related]
4. Effects of pharmacist prescribing on patient outcomes in the hospital setting: a systematic review.
Poh EW; McArthur A; Stephenson M; Roughead EE
JBI Database System Rev Implement Rep; 2018 Sep; 16(9):1823-1873. PubMed ID: 30204671
[TBL] [Abstract][Full Text] [Related]
5. Identifying Community Pharmacist Preferences For Prescribing Services in Primary Care in New Zealand: A Discrete Choice Experiment.
Raghunandan R; Howard K; Marra CA; Tordoff J; Smith A
Appl Health Econ Health Policy; 2021 Mar; 19(2):253-266. PubMed ID: 33073328
[TBL] [Abstract][Full Text] [Related]
6. Assessing pharmacist and clinician perspectives on pharmacist-prescribed hormonal contraceptives.
Whalen A; Bratberg J; Cohen L; Orr K; Lemay V
J Am Pharm Assoc (2003); 2024; 64(1):314-320.e3. PubMed ID: 37967721
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Identifying New Zealand Public Preferences for Pharmacist Prescribers in Primary Care: A Discrete Choice Experiment.
Raghunandan R; Howard K; Marra CA; Tordoff J; Smith A
Patient; 2022 Jan; 15(1):77-92. PubMed ID: 34109570
[TBL] [Abstract][Full Text] [Related]
9. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns.
Nkansah N; Mostovetsky O; Yu C; Chheng T; Beney J; Bond CM; Bero L
Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD000336. PubMed ID: 20614422
[TBL] [Abstract][Full Text] [Related]
10. Stakeholders' views on granting prescribing authority to pharmacists in Nigeria: a qualitative study.
Auta A; Strickland-Hodge B; Maz J
Int J Clin Pharm; 2016 Aug; 38(4):960-7. PubMed ID: 27194098
[TBL] [Abstract][Full Text] [Related]
11. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.
Weeks G; George J; Maclure K; Stewart D
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011227. PubMed ID: 27873322
[TBL] [Abstract][Full Text] [Related]
12. Examining non-medical prescribing trends in New Zealand: 2016-2020.
Raghunandan R; Marra CA; Tordoff J; Smith A
BMC Health Serv Res; 2021 May; 21(1):418. PubMed ID: 33941188
[TBL] [Abstract][Full Text] [Related]
13. Assessing the contribution of prescribing in primary care by nurses and professionals allied to medicine: a systematic review of literature.
Bhanbhro S; Drennan VM; Grant R; Harris R
BMC Health Serv Res; 2011 Dec; 11():330. PubMed ID: 22136294
[TBL] [Abstract][Full Text] [Related]
14. Stakeholders' views of UK nurse and pharmacist supplementary prescribing.
Cooper R; Anderson C; Avery T; Bissell P; Guillaume L; Hutchinson A; Lymn J; Murphy E; Ratcliffe J; Ward P
J Health Serv Res Policy; 2008 Oct; 13(4):215-21. PubMed ID: 18806179
[TBL] [Abstract][Full Text] [Related]
15. Benefits and barriers associated with e-prescribing in community pharmacy - A systematic review.
Hareem A; Lee J; Stupans I; Park JS; Wang K
Explor Res Clin Soc Pharm; 2023 Dec; 12():100375. PubMed ID: 38145236
[TBL] [Abstract][Full Text] [Related]
16. Pharmacist prescribing: A scoping review about the views and experiences of patients and the public.
Famiyeh IM; McCarthy L
Res Social Adm Pharm; 2017; 13(1):1-16. PubMed ID: 26898951
[TBL] [Abstract][Full Text] [Related]
17. Stakeholders' views and experiences of pharmacist prescribing: a systematic review.
Jebara T; Cunningham S; MacLure K; Awaisu A; Pallivalapila A; Stewart D
Br J Clin Pharmacol; 2018 Sep; 84(9):1883-1905. PubMed ID: 29873098
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
